The dermatology market’s allure lies in its promising market dynamics, including opportunities for consolidating practices, leveraging economies of scale, and optimizing operational efficiencies. Additionally, the growing consumer awareness and emphasis on skin health have contributed to a robust and expanding market demand. With relatively favorable reimbursement structures, evolving regulations, and technological advancements supporting the sector, PE firms are keen to invest in dermatology practices and capitalize on their growth potential, VMG Health reports. Read more.
Related Posts
HCA Healthcare Intentionally Overcharged Patients, Lawsuit Alleges
The allegations were made by two long-time emergency room doctors.
June 20, 2023
Nursing Homes, Hospices, Other Businesses Sold as Hospitals Refocus
Since the onset of the COVID-19 pandemic, an increasing number of hospital operators have divested long-term care, skilled nursing and other businesses as labor and supplies costs have surged and regulators crack down on post-acute providers.
August 29, 2023
Walgreens Raises Healthcare Segment Outlook on Summit Acquisition
Walgreens expects the segment to bring in between $14.5 billion and $16 billion in sales in 2025, up from the previous guidance of between $11 billion and $12 billion for that year.
January 5, 2023
Amedisys CEO: Shrinking Hospice Market to Bounce Back by 2023
During the past two years hospices have contended with worsening staff shortages, rising supply costs, increased paid leave and employee quarantines due to the pandemic.
November 11, 2021